medac Diagnostics is expanding GeneProof’s CE IVD test portfolio for sexually transmitted infections (STI) with tests for T. pallidum und T. vaginalis.
With the next multiplex test for M. hominis (MH), U. urealyticum (UU) and U. parvum (UP), there are additional combination options for specific investigations and symptom-specific differential diagnoses.
Each PCR test contains one properly ready-to-use master mix in only one tube. Once the addition of the extracted nucleic acid has been performed, no further pipetting steps are required. In addition, the ready-to-use master mix contains uracil-DNA glycosylase (UDG) to eliminate false-positive results.
All PCR tests are in compliance with the guidelines of the German Medical Association for quality assurance in medical laboratories (Rili-BÄK) and therefore contain extraction and amplification controls.
Thanks to the consistent temperature profile, all tests can run simultaneously on one PCR cycler.
The PCR is based on “hot start” technology to minimise non-specific reactions and achieve maximum sensitivity.
The kits are designed for in vitro diagnostics and provide qualitative detection.
CE IVD

• Homepage Brochure Diagnostic sexual transmitted infections (STI)